Northville, MI, United States of America

Jung H Kim

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jung H. Kim: Pioneering Chromosomal Abnormality Detection

Introduction

Jung H. Kim, an influential inventor based in Northville, MI, has made significant contributions to the field of molecular diagnostics. With a focus on detecting chromosomal abnormalities, his innovative approaches have the potential to enhance genetic testing and diagnostics, catering to critical medical needs.

Latest Patents

Jung H. Kim holds two notable patents that revolve around nucleic acids and methods for detecting chromosomal abnormalities, particularly aneuploidy. His latest patents detail methods and nucleic acid molecules for identifying these abnormalities, including techniques for selecting appropriate nucleic acid molecules for use. These advancements serve as pivotal tools in genetic research and clinical diagnostics.

Career Highlights

Currently employed at Progenity, Inc., Jung H. Kim leverages his expertise to advance the company's mission of transforming genetic testing. His role at Progenity positions him at the forefront of innovation in the diagnostics industry, where he applies his knowledge in developing groundbreaking techniques for detecting chromosomal abnormalities.

Collaborations

Throughout his career, Jung has collaborated with talented professionals, including colleagues Tobias Mann and Heng Wang. This teamwork has been instrumental in fostering creativity and driving the innovative process within the realm of genetic diagnostics, leading to impactful developments in their field.

Conclusion

Jung H. Kim's contributions to the detection of chromosomal abnormalities position him as a notable inventor in the field of genetics. Through his pioneering patents and collaboration with skilled coworkers, he continues to shape the future of molecular diagnostics, bringing advancements that have the potential to improve patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…